What is dementia?
Dementia is a group of symptoms that affect memory, thinking, problem-solving and daily activities.1 The most common type is Alzheimer’s disease. Other forms include vascular dementia, Lewy body dementia, mixed dementia and frontotemporal dementia.2
Common signs of dementia include:
- Forgetting conversations or appointments
- Trouble finding the right words
- Difficulty paying bills or managing money
- Losing interest in hobbies or social events
- Noticeable changes in mood or personality
Alzheimer’s disease makes up about 80 percent of dementia cases. Vascular dementia, caused by poor blood flow to the brain, is the second most common type. Lewy body dementia often brings movement problems as well as memory loss. Frontotemporal dementia affects behavior and language before memory. Mixed dementia involves more than one cause.3
The Centers for Medicare & Medicaid Services (CMS) reports that dementia affects more than 6 million Americans over age 65. That number is expected to more than double by 2060.4 Early prevention and care planning are key to improving quality of life and reducing healthcare costs.
What are statins?
Statins are prescription medications that lower cholesterol in the blood. Doctors often prescribe them when diet and lifestyle changes are not effective. They are used to reduce the risk of heart attack or stroke, especially if you have other risk factors such as diabetes, high blood pressure or a family history of heart disease.5
Examples of statins include:
- Atorvastatin (Lipitor)
- Simvastatin (Zocor)
- Rosuvastatin (Crestor)
- Pravastatin (Pravachol)
- Lovastatin (Mevacor)
- Fluvastatin (Lescol)
Statins block an enzyme in the liver that produces cholesterol. With less cholesterol in your blood, less plaque builds up in your arteries. This helps keep blood moving to your heart and brain.6
Close to 38 million Americans take statins, and Medicare Part D covers them for older adults at risk of cardiovascular disease.7 They are considered one of the most effective tools for preventing heart-related hospitalizations.
What the FDA says about statins and memory
The U.S. Food and Drug Administration (FDA) has carefully studied statins and their possible effects on memory. In 2012, the FDA updated safety labels to include information about cognitive side effects.8
The FDA noted that some people taking statins reported memory loss, forgetfulness and confusion. These symptoms were usually mild and went away after stopping the medication. The reports, which came from adults over 50, showed that memory problems could appear at any time—sometimes within days, other times after years of use.
Importantly, the FDA did not find evidence that statins cause permanent dementia, such as Alzheimer’s disease. Instead, the memory changes reported were temporary and reversible. This remains a key point in the ongoing discussion about statins and dementia, helping patients weigh benefits against potential cognitive side effects.
For most people, the benefits of statins in lowering cholesterol and reducing the risk of heart attack and stroke are greater than the small risk of these mild memory issues. Still, the FDA advises you to pay attention to changes in your memory or thinking and to discuss them with your healthcare provider if you notice them.
What the research says about statins and cognitive function
So, what does science say? Researchers have been investigating the relationship between statins and memory for over 20 years. While early reports raised concerns, large studies and reviews now suggest that statins are not a major cause of dementia. Some evidence shows they may even lower the risk of certain types of memory decline.
- Statins may lower the risk of dementia and Alzheimer’s disease. A 2018 review in Scientific Reports looked at 25 studies. It found that people taking statins had a lower risk of dementia, Alzheimer’s disease and mild cognitive impairment.
- The benefit did not appear as strong for vascular dementia, but overall, statins were linked with better brain outcomes in older adults.9
- The same analysis suggested that different types of statins could affect the brain in different ways. Hydrophilic statins, like rosuvastatin and pravastatin, lower the overall risk of dementia. In contrast, lipophilic statins, such as simvastatin, atorvastatin and lovastatin, are more strongly linked to a reduced risk of Alzheimer’s disease. This detail is still being studied, but it suggests that the type of statin prescribed may play a role in brain health.
- Memory issues are usually temporary. Some people taking statins have reported confusion or forgetfulness. These side effects are generally mild and reversible. They aren’t connected to severe conditions like Alzheimer’s disease.10
- Statins may support brain health by reducing inflammation and enhancing blood flow. Over time, this can help prevent the small strokes and tissue damage linked to memory decline.11
Overall, research indicates that statins do not increase the risk of dementia. In fact, they may help protect the brain for some people, especially those using them to manage heart disease or prevent strokes. By supporting healthy blood flow and reducing inflammation, statins may also help slow age-related changes that affect memory over time.
How cholesterol may affect the brain
Your brain needs cholesterol to function correctly. It helps build cell walls, repair nerves and produce essential hormones. About one-fourth of all the cholesterol in your body is found in the brain.12
When cholesterol levels get too high, problems can develop. Excess cholesterol can narrow or block blood vessels, reducing blood flow and increasing the risk of stroke.13 High cholesterol may also contribute to the buildup of amyloid plaques, the sticky deposits linked to Alzheimer’s disease.
By helping lower cholesterol, statins may protect brain health and circulation. While lowering cholesterol too much is rarely a concern, most research indicates that maintaining levels within a healthy range offers far more benefits than risks.
Is there a risk of dementia from taking statins?
Concerns about statins and dementia have been widely studied, but current evidence shows no clear or consistent connection. Most people who take statins do not develop memory problems as a result. A few may notice mild confusion or forgetfulness, but these symptoms usually improve after adjusting the dose or switching medications.
Overall, the evidence shows that statins do not increase the risk of developing dementia. By lowering cholesterol and reducing the chance of stroke, they may help protect long-term brain health.
Who is most likely to experience cognitive issues from statins?
Not everyone responds to medicines the same way. Some individuals may be more susceptible to noticing memory changes while taking statins. Risk factors may include:
- Being over the age of 75
- Taking high doses of statins
- Using more than one medicine that affects brain function
- Having other medical conditions, like diabetes or a prior stroke
- Having a strong family history of dementia
It’s important to remember that age itself is the strongest risk factor for dementia. If memory problems occur while taking statins, they may be related to natural aging or another underlying illness.
What you should do if you think statins affect your memory
If you or a loved one notices new memory problems while taking statins, don’t stop your medication on your own. Stopping suddenly could raise your risk of a heart attack or stroke.
Instead, talk to your doctor. They may:
- Review all of your medicines
- Check for other causes of memory changes
- Adjust the dose
- Switch you to a different type of statin
- Suggest non-medication steps like healthy eating, exercise and brain activities
Balancing the risks and benefits of statins
Here is a simple way to look at the pros and cons:
| Benefits of statins | Possible risks |
|---|---|
| Lower cholesterol | Mild memory issues (rare, temporary) |
| Reduce the risk of stroke | Muscle aches or cramps |
| Reduce the risk of heart attack | Liver enzyme changes |
| May protect against dementia | Slight increase in blood sugar |
For most older adults, the benefits of statins far outweigh the risks.
Lifestyle changes that support brain and heart health
Statins are only one part of protecting your health. You can also support your brain and heart by:
- Eating a diet rich in vegetables, fish, nuts and whole grains
- Controlling blood pressure and blood sugar
- Avoiding smoking and limiting alcohol
- Staying socially active
- Keeping your brain active with reading, puzzles or learning new skills
These steps, along with your medication, offer the best protection.
When to see your doctor
It can be challenging to determine whether memory problems are a normal part of aging or a more serious issue. You should call your doctor if you notice:
- Sudden confusion or trouble finding your way home
- Memory loss that affects your daily tasks, like paying bills or remembering medications
- Major mood or personality changes
- Trouble with speech, vision or movement
These symptoms may not be caused by statins at all. They could be related to dementia, stroke or another medical issue that needs attention. The sooner you seek help, the better your chances for treatment and support.
Future research and unanswered questions
Researchers are still learning about the effects of statins on the brain. Ongoing studies are exploring:
- Whether certain statins are more protective than others
- How genetics may play a role in who experiences memory side effects
- Whether starting statins earlier in life reduces dementia risk later on
- The best balance between lowering cholesterol and maintaining brain health
As research continues, guidelines are likely to change. For now, the consensus remains: statins are safe and effective for most older adults.15
FAQs about statins and dementia
Do statins cause dementia?
No. Large studies show no strong link. Some people might feel confused at first, but this usually goes away quickly.
Can statins protect against dementia?
Yes. Some evidence suggests that they lower the risk of dementia. They do this by reducing stroke and blood vessel damage.
Which statin is safest for older adults?
There isn’t one single “best” statin. Your doctor will choose based on your health and other medicines.
Should I stop my statin if I have memory problems?
No. Talk to your doctor before stopping. Stopping suddenly can be dangerous.
Does Medicare cover statins?
Yes. Statins are widely covered under Medicare Part D for eligible patients.
The bottom line
Statins are among the most common medications used to protect heart health. While concerns about memory have been raised, research shows that statins do not cause dementia. They may protect the brain by lowering cholesterol levels and reducing the risk of stroke.
If you notice memory changes, don’t panic. Talk to your doctor. Together, you can decide what’s best for your heart, your brain and your overall health.
For more support and resources, visit WellMed Healthcare.
References
- 1. Alzheimer’s Association. “What Is Dementia?” Accessed October 2, 2025. https://www.alz.org/alzheimers-dementia/what-is-dementia
- 2. Alzheimer’s Association. “Types of Dementia.” Accessed October 2, 2025. https://www.alz.org/alzheimer-s-dementia/what-is-dementia/types-of-dementia
- 3. Alzheimer’s Association. “Mixed Dementia.” Accessed October 2, 2025. https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/mixed-dementia
- 4. Centers for Medicare & Medicaid Services. “Guiding an Improved Dementia Experience (GUIDE) Model.” Accessed October 2, 2025. https://www.cms.gov/priorities/innovation/innovation-models/guide
- 5. MedlinePlus. “Statins.” Accessed October 2, 2025. https://medlineplus.gov/statins.html
- 6. Sizar, Omeed, Swapnil Khare, Preeti Patel, and Raja Talati. “Statin Medications.” StatPearls, February 9, 2024. https://www.ncbi.nlm.nih.gov/books/NBK430940/
- 7. Jacobs, Joshua A., Daniel K. Addo, Alexander R. Zheutlin, et al. “Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US.” JAMA Cardiology, March 22, 2023. https://jamanetwork.com/journals/jamacardiology/fullarticle/2802859?utm
- 8. U.S. Food and Drug Administration. “FDA Drug Safety Communication: Important Safety Label Changes to Cholesterol-Lowering Statin Drugs.” January 19, 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs#pat
- 9. Chu, Che-Sheng, Ping-Tao Tseng, Brendon Stubbs, Tien-Yu Chen, Chia-Hung Tang, Dian-Jeng Li, Wei-Cheng Yang, Yen-Wen Chen, Ching-Kuan Wu, Nicola Veronese, Andre F. Carvalho, Brisa S. Fernandes, Nathan Herrmann, and Pao-Yen Lin. “Use of Statins and the Risk of Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.” Scientific Reports 8, no. 1 (April 11, 2018). https://pubmed.ncbi.nlm.nih.gov/29643479/
- 10. Kelley, Brendan J., and Stephen Glasser. “Cognitive Effects of Statin Medications.” CNS Drugs 28, no. 5 (May 2014): 411–419. https://pubmed.ncbi.nlm.nih.gov/24504830/
- 11. Fracassi, Anna, Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni, and Marco Segatto. 2019. “Statins and the Brain: More than Lipid Lowering Agents?” Current Neuropharmacology 17 (1): 59–83. https://pmc.ncbi.nlm.nih.gov/articles/PMC6341496/
- 12. Ho, Wan Y., Hannelore Hartmann, and Shuo-Chien Ling. “Central Nervous System Cholesterol Metabolism in Health and Disease.” IUBMB Life 74, no. 8 (August 2022): 826–841. https://pubmed.ncbi.nlm.nih.gov/35836360/
- 13. Goldstein, Larry B., Peter P. Toth, Jennifer L. Dearborn-Tomazos, Robert P. Giugliano, Benjamin J. Hirsh, Jessica M. Peña, Magdy H. Selim, and Daniel Woo. “Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association.” Arteriosclerosis, Thrombosis, and Vascular Biology, September 14, 2023. https://www.ahajournals.org/doi/full/10.1161/ATV.0000000000000164?
- 14. Zimmerman, Scott C., Minhyuk Choi, Chen Jiang, Erin L. Ferguson, Thomas J. Hoffmann, Kaitlin Swinnerton, Akinyemi Oni-Orisan, et al. “Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation Study.” Neurology 105, no. 2 (July 22, 2025). https://pubmed.ncbi.nlm.nih.gov/40577672/
- 15. Zhou, Zhen, Joanne Ryan, Michael E. Ernst, Sophia Zoungas, Andrew M. Tonkin, Robyn L. Woods, John J. McNeil, et al. “Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults: ASPREE Investigator Group Observational Study.” Journal of the American College of Cardiology 77, no. 25 (June 29, 2021). https://pubmed.ncbi.nlm.nih.gov/34167639/